Qualigen Therapeutics ( (QLGN) ) has released a notification of late filing.
Qualigen Therapeutics, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for this delay is the difficulty in obtaining and compiling the necessary information, which could not be resolved without unreasonable effort and expense. The company anticipates filing the delayed report within 15 calendar days following the original due date. There are no expected significant changes in financial results from the previous year. The company remains committed to compliance, with the notification signed by Kevin Richardson II.
More about Qualigen Therapeutics
YTD Price Performance: -13.33%
Average Trading Volume: 63,583
Technical Sentiment Signal: Buy
Current Market Cap: $2.8M
See more insights into QLGN stock on TipRanks’ Stock Analysis page.